The medication olokizumab improves outcomes for up to 48 weeks in patients with rheumatoid arthritis, investigators recently reported at a conference.
Source link
Would you like to get the test?
The medication olokizumab improves outcomes for up to 48 weeks in patients with rheumatoid arthritis, investigators recently reported at a conference.
Source link
Would you like to get the test?